Analysis News

  • The best newsletter in the market
  • Customisable and personal
  • By e-mail every morning, for free

Receive Analysis News:

EMail:

Free daily newsletter every morning

Content
Signals
All indicators - Medium term
SPDR S&P 500 ETFDec 14, 2018
S&P 500 Index IsharesDec 14, 2018
Johnson & JohnsonDec 14, 2018
Healthcare Select SectDec 14, 2018
Consumer Staples SelecDec 14, 2018

The market showed a negative development Friday, and Nasdaq Combined Composite Index (COMPX) ended the day at 6911 points, which is a decline of 2.26 percent. The week as a whole showed a loss of 0.8%.

1080 shares showed a gain and 4399 showed a loss. 145 shares were unchanged and closed at the same price as the previous day. There was no trading in 1720 shares.

Value of the total volume of shares and primary capital certificates traded Friday was approximately 356.7 billion.

SPDR S&P 500 ETF (SPY) developed negatively and fell 1.85 percent to a close of 260 dollar. We must go back to Apr 6 to find a lower close for the stock. The stock triggered a sell signal by the break down through the support at 263 dollar in a rectangle formation. A further drop to 247 dollar within three months is indicated.
Johnson & Johnson (JNJ) closed at 133 dollar after posting a loss of 10.04 percent. We must go back to Jul 19. 2002 to find an equally steep drop. That time the stock lost 15.85 percent. The volume was also high. At session end it was bought and sold shares for about 7733 million dollar in the stock, which equals seven times mean daily turnover. Nor technically does it look good. The stock is trend wise positive in the medium term, but has broken down through the support at 134 dollar.
JP Morgan Chase & Co (JPM) developed negatively and fell 0.82 percent to a close of 100 dollar. We must go back to Nov 2017 to find a lower close for the stock. It does not look good technically either. The stock is trend wise negative in the medium term and a further decline is indicated.
S&P 500 Index Ishares (IVV) was down 1.81 percent to close at 262 dollar. We must go back to Apr 6 to find a lower close for the stock. The stock triggered a sell signal by the break down through the support at 265 dollar in a rectangle formation. A further drop to 249 dollar within three months is indicated.
Healthcare Select Sector SPDR (XLV) closed at 88.96 dollar after posting a loss of 3.37 percent. The stock has never lost more in one day since Feb 8, when it was down 3.47 percent. The stock is trend wise positive in the medium term.

Lowest close since Apr 2.
The market showed a negative development Friday, and S&P 500 (US500) ended the day at 2600 points, which is a decline of 1.91 percent. The index has not closed lower since Apr 2. For the week as a whole the index showed a loss of 1.3%. The index triggered a sell signal by the break down through the support at 2626 points in a rectangle formation. A further drop to 2468 points within three months is indicated.

Indices
S&P 500
   Neutral
S&P 500 has broken the floor of the rising trend channel in the medium long term, which indicates a weaker initial rising rate. Has broken a rectangle formation. A decisive break of the support at 2626 will signal a further fall to 2468 or less. The index is between the support at points 2580 and the resistance at points 2635. A definitive break through of one of these levels predicts the new direction. The index is overall assessed as technically neutral for the medium long term.
Today´s Case
Ultrapro Short S&P 500 Proshares (SPXU) Price 43.09, Dec 14, 2018
Ultrapro Short S&P 500 Proshares is in a rising trend channel in the medium long term. Rising trends indicate that the company experiences positive development and that buy interest among investors is increasing. Has broken through the ceiling at 42.19 of a rectangle pattern. A decisive break will signal a further rise to 51.07 or more. The stock has broken up through the resistance at dollar 41.40. This predicts a further rise. Positive volume balance strengthens the stock in the short term. The stock is overall assessed as technically positive for the medium long term.
Recommendation: Positive
Latest days indices
AEX-0.34%506.53
ATX0.00%3406.09
CAC40-0.88%4853.70
COMPX-2.26%6910.66
DAX-0.54%10866
HEX0.22%9046.55
N100-0.77%943.28
OMXC25GI-0.24%1093.66
OMXSPI-0.54%545.09
OSEBX-0.94%830.76
PSI20-0.41%4803.42
TECDAX-1.08%2519.83
UKX-0.47%6845.17
EURUSD-0.44%113.0400
CL (OIL)-2.62%51.20
Indices Evaluations
 SML
AEXnegnegneg
ATXneutralneutralneutral
CAC40negnegneutral
COMPXneutralposneutral
DAXnegnegneg
HEXneutralneutralneutral
N100negneutralneutral
OMXC25GIposnegpos
OMXSPInegneutralneutral
OSEBXnegnegneutral
PSI20neutralnegpos
TECDAXneutralnegneutral
UKXnegnegneg
EURUSDnegnegneg
CL (OIL)negnegneg

S: Short term.    M: Medium term.    L: Long term.
Stock Exchange barometer
US Stocks - Medium term
 
      
12% 46% 42%
 901 Buy Candidates
 3416 Neutral
 3062 Sell Candidates
Cancel Analysis News
Disclaimer Copyright © 2018 Investtech.com AS, Org nr 978 655 424 MVA


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

[ Back to default newsletter setup ]

Customised newsletter

Investtech subscribers can customise AnalysisNews. Add your own stocks, your own portfolios, etc, and get the updates directly to your inbox. A customised newsletter is the best way to get a daily overview of the market and your own investments.
Wherever you see this button, you can click it in order to add a simplified version of the page to AnalysisNews or to your start page.

Edit AnalysisNews

Register as a recipient of AnalysisNews in order to customise the content.
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now